David W. Beeson
Headley Way
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications
Positive allosteric modulator selective for adult muscle nicotinic acetylcholine receptor.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 02, 2026
The Differing Phenotypes of the Three Most Common Postsynaptic Congenital Myasthenic Syndromes Governed by Their Underlying Molecular Pathogenic Mechanisms.
Journal: Muscle & nerve
Published: October 23, 2025
Myasthenic syndromes: mistaking genetic for acquired.
Journal: Practical neurology
Published: July 01, 2025
Congenital myasthenic syndrome: is it time for a name change to genetic myasthenic syndrome?
Journal: Brain : a journal of neurology
Published: April 17, 2025
Congenital myasthenic syndrome: is it time for a name change to genetic myasthenic syndrome?
Journal: Brain : a journal of neurology
Published: April 17, 2025
Structures of the human adult muscle-type nicotinic receptor in resting and desensitized states.
Journal: Cell reports
Published: December 02, 2024
Assessing the Utility of ColabFold and AlphaMissense in Determining Missense Variant Pathogenicity for Congenital Myasthenic Syndromes.
Journal: Biomedicines
Published: October 03, 2024
Congenital myasthenic syndromes: increasingly complex.
Journal: Current opinion in neurology
Published: July 25, 2024
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia.
Journal: Brain communications
Published: March 12, 2024
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia.
Journal: bioRxiv : the preprint server for biology
Published: February 26, 2024
Last Updated: 09/26/2026